Integer Holdings Corporation (ITGR)

NYSE: ITGR · IEX Real-Time Price · USD
80.49
1.60 (2.03%)
May 27, 2022 4:00 PM EDT - Market closed
Market Cap2.66B
Revenue (ttm)1.24B
Net Income (ttm)86.66M
Shares Out33.10M
EPS (ttm)2.60
PE Ratio30.92
Forward PE16.67
Dividendn/a
Ex-Dividend Daten/a
Volume95,973
Open79.75
Previous Close78.89
Day's Range79.19 - 80.57
52-Week Range68.58 - 101.61
Beta1.28
AnalystsBuy
Price Target113.56 (+41.1%)
Earnings DateApr 28, 2022

About ITGR

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemaker...

IndustryHealth Care Equipment & Supplies
IPO DateSep 29, 2000
CEOJoseph Dziedzic
Employees9,000
Stock ExchangeNYSE
Ticker SymbolITGR
Full Company Profile

Financial Performance

In 2021, ITGR's revenue was $1.22 billion, an increase of 13.75% compared to the previous year's $1.07 billion. Earnings were $96.81 million, an increase of 25.30%.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for ITGR stock is "Buy." The 12-month stock price forecast is 113.56, which is an increase of 41.09% from the latest price.

Price Target
$113.56
(41.09% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Integer Holdings (ITGR) Q1 Earnings, Revenues Lag Estimates

Integer Holdings' (ITGR) first-quarter results reflect robust segmental performances besides strength in the majority of the product lines.

3 weeks ago - Zacks Investment Research

Integer (ITGR) Lags Q1 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of -12.36% and 1.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

4 weeks ago - Zacks Investment Research

Integer Holdings Corporation Reports First Quarter 2022 Results

~ 1Q22 sales and profit consistent with expectations ~ ~ 2022 outlook updated for Aran Biomedical acquisition ~

4 weeks ago - GlobeNewsWire

Final Trades: Integer, Electric Vehicles ETF, Marriott & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other symbols:MARFDRVVST
1 month ago - CNBC Television

Integer Holdings' (ITGR) Latest Buyout to Expand Its Footprint

Integer Holdings' (ITGR) buyout of Aran Biomedical is set to expand its presence in high-growth markets as well as enhance its product offerings.

1 month ago - Zacks Investment Research

Integer Adds Proprietary Biomaterial Technologies Via €120M Acquisition

Integer Holdings Corporation (NYSE: ITGR) acquired Connemara Biomedical Holdings Teoranta and its subsidiaries Aran Biomedical and Proxy Biomedical. Aran offers medical textiles, high precision biomater...

1 month ago - Benzinga

Integer Holdings Corporation Acquires Aran Biomedical

~ Acquisition brings highly differentiated, proprietary biomaterial technologies for implantable cardiovascular devices to enable our customers' innovation ~

1 month ago - GlobeNewsWire

3 Stocks Institutional Investors Can't Get Enough Of

Learning who holds the most shares in a particular company can help investors understand what dictates stock price changes.

Other symbols:BBWITHRM
1 month ago - MarketBeat

Integer Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022

PLANO, Texas, March 24, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2022, at 7 a.m. Cen...

2 months ago - GlobeNewsWire

Integer to Take Part in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum

PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, and Jason Garland, Executive Vice Pres...

2 months ago - GlobeNewsWire

Integer Announces Board Leadership Transition

PLANO, Texas, March 17, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, announced today that Bill R. Sanford will be retiring as...

2 months ago - GlobeNewsWire

Integer Holdings (ITGR) Q4 Earnings, Revenues Top Estimates

Integer Holdings' (ITGR) fourth-quarter results reflect robust segmental performances besides strength in the majority of the product lines.

3 months ago - Zacks Investment Research

Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2021

~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Completed acquisition of Oscor Inc. ~ ~ Generated $157 million cash flow from operations in the full year ~

3 months ago - GlobeNewsWire

Integer Schedules Fourth Quarter and Full-Year 2021 Earnings Release and Conference Call for February 17, 2022

PLANO, Texas, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year 2021,...

4 months ago - GlobeNewsWire

3 Reasons to Retain Integer Holdings (ITGR) Stock For Now

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and solid foothold in the broader MedTech space.

4 months ago - Zacks Investment Research

Integer Holdings (ITGR) Buys Oscor, Boosts Global Footprint

Integer Holdings' (ITGR) acquisition of Oscor is likely to bolster its already solid global presence.

5 months ago - Zacks Investment Research

Integer Holdings Corporation Completes Acquisition of Oscor, Inc.

Acquisition expands Integer's cardiovascular and neurostimulation product portfolio through broadened product offering and addition of low-cost manufacturing capacity Acquisition expands Integer's cardi...

5 months ago - GlobeNewsWire

Integer Holdings (ITGR) Beats on Q3 Earnings, Ups 2021 EPS View

Integer Holdings' (ITGR) third-quarter results reflect robust segmental performances along with strength in the majority of the product lines.

6 months ago - Zacks Investment Research

Integer's Q3 Beats Street View; Announces Oscor Acquisition For $220M

Integer Holdings Corporation (NYSE: ITGR) posted Q3 sales of $305.57 million, +30% Y/Y, beating the consensus of $303.23 million. Q3 adjusted EPS more than doubled to $1.05, ahead of the consensus of $0...

6 months ago - Benzinga

Integer (ITGR) Tops Q3 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of 9.37% and 0.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Integer Holdings Corporation Reports Third Quarter 2021 Results

~ Strong sales and profit growth vs. last year ~ ~ Increased 2021 outlook ~ ~ Integer to acquire Oscor, Inc. ~

6 months ago - GlobeNewsWire

Integer (ITGR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

Integer Holdings (ITGR) continues to gain traction from portfolio management. However, intense competition is a woe.

7 months ago - Zacks Investment Research

Integer Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021

PLANO, Texas, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2021, at 7 a.m. Cen...

7 months ago - GlobeNewsWire

3 Promising MedTech Stocks to Snap Up in Second-Half 2021

Backed by robust long-term prospects, investors can add three lucrative MedTech stocks, MMSI, ITGR and OFIX, to their watchlist.

Other symbols:MMSIOFIX
8 months ago - Zacks Investment Research